Valuation : MDxHealth SA

Market Cap 59.26M 68.77M 55.56M 50.72M 95.54M 6.57B 95.85M 659M 257M 3.32B 258M 253M 11B P/E 2026 *
-1.4x
P/E 2027 * -2.53x
Enterprise Value 180M 209M 169M 154M 290M 19.96B 291M 2B 781M 10.08B 784M 767M 33.42B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.82x
Free-Float
77.86%
Yield 2026 *
-
Yield 2027 * -
1 day-0.11%
1 week-3.01%
Current month+72.42%
1 month+80.08%
3 months-5.16%
6 months-78.80%
Current year-79.81%
1 week 0.68
Extreme 0.68
0.8
1 month 0.41
Extreme 0.4076
1.13
Current year 0.4
Extreme 0.4
4.34
1 year 0.4
Extreme 0.4
5.33
3 years 0.4
Extreme 0.4
5.33
5 years 0
Extreme 1.0E-5
14.8
10 years 0
Extreme 1.0E-5
61.5
Manager TitleAgeSince
Chief Executive Officer 64 2019-02-17
Director of Finance/CFO 52 2019-07-21
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 2017-10-31
Chairman 58 2017-12-31
Director/Board Member 64 2019-02-17
Date Insider Type Main position Quantity % Market Cap.
8/13/26
MVM Partners LLC
BuyCompany 2,202,643 2.3084%
6/1/26 Free

Chairman

10,000 0.0195%
6/1/26 Free

Chief Executive Officer

942,200 1.8343%
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%-3.01%-79.70%-79.41% 68.77M
-0.78%-1.42%+2.96%+21.65% 50.47B
-6.00%-0.75%+447.48%+535.14% 44.56B
-0.24%+0.74%+37.18%+16.26% 43.08B
-1.55%-2.07%+19.83%+71.70% 41.7B
-0.31%-0.83%+19.47%+48.24% 33.21B
-1.79%-3.24%+26.32%+125.06% 16.77B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.63%+27.62% 14.58B
-1.66%-1.25%+78.49%+42.97% 13.92B
Average -1.39%-1.25%+62.63%+89.91% 27.46B
Weighted average by Cap. -1.70%-1.06%+96.23%+128.98%

Financials

2026 *2027 *
Net sales 96.12M 112M 90.12M 82.27M 155M 10.66B 155M 1.07B 417M 5.38B 419M 410M 17.84B 109M 126M 102M 93.15M 175M 12.07B 176M 1.21B 472M 6.09B 474M 464M 20.2B
Net income -29.64M -34.4M -27.79M -25.37M -47.79M -3.29B -47.94M -330M -129M -1.66B -129M -126M -5.5B -18.12M -21.03M -16.99M -15.51M -29.22M -2.01B -29.31M -202M -78.64M -1.01B -78.95M -77.23M -3.36B
Net Debt 121M 140M 113M 103M 195M 13.39B 195M 1.34B 524M 6.76B 526M 515M 22.42B 139M 161M 130M 119M 224M 15.38B 224M 1.54B 602M 7.76B 604M 591M 25.75B
Logo MDxHealth SA
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Employees
364
Date Price Change Volume
26-08-28 US$0.7207 -0.11% 277,130
26-08-27 US$0.7215 -4.58% 270,931
26-08-26 US$0.7561 -4.15% 192,530
26-08-25 US$0.7888 +6.41% 430,583
26-08-24 US$0.7413 -0.24% 401,868
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.7207USD
Average target price
1.800USD
Spread / Average Target
+149.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MDXH Stock